tricycloquinazoline has been researched along with 3-methylcholanthrene in 1 studies
Studies (tricycloquinazoline) | Trials (tricycloquinazoline) | Recent Studies (post-2010) (tricycloquinazoline) | Studies (3-methylcholanthrene) | Trials (3-methylcholanthrene) | Recent Studies (post-2010) (3-methylcholanthrene) |
---|---|---|---|---|---|
8 | 0 | 0 | 7,215 | 1 | 158 |
Protein | Taxonomy | tricycloquinazoline (IC50) | 3-methylcholanthrene (IC50) |
---|---|---|---|
Cytochrome P450 1A2 | Homo sapiens (human) | 0.3 | |
Adenosine receptor A3 | Homo sapiens (human) | 5.544 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.544 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.544 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
GOSWAMI, PK | 1 |
1 other study(ies) available for tricycloquinazoline and 3-methylcholanthrene
Article | Year |
---|---|
EOSINOPHIL LEUCOCYTE REACTION TO TRICYCLOQUINAZOLINE-TREATED CELLS AND TO THIS CHEMICAL.
Topics: Carcinogens; Eosinophils; Heterocyclic Compounds; Leukocyte Count; Leukocytosis; Liver; Methylcholanthrene; Mice; Pharmacology; Quinazolines; Research | 1964 |